Epstein–Barr Virus in Hodgkin’s Disease
Author Information
Author(s): Axdorph U, Porwit-MacDonald A, Sjöberg J, Grimfors G, Ekman M, Wang W, Biberfeld P, Björkholm M
Primary Institution: Department of Medicine, Division of Haematology Institutet
Hypothesis
How does Epstein–Barr virus expression relate to patient characteristics and blood lymphocyte function in Hodgkin’s disease?
Conclusion
Patients with Epstein–Barr virus positive tumors had elevated levels of certain serum factors and lower white blood cell counts, but clinical outcomes were not related to tumor EBV status.
Supporting Evidence
- 33% of patients were EBV positive.
- 58% of mixed cellularity histopathology cases were EBV positive.
- EBV positive patients had significantly lower total white blood cell counts.
- EBV positive patients had significantly higher levels of sCD54.
Takeaway
This study looked at how a virus called Epstein–Barr affects people with a type of cancer called Hodgkin’s disease. They found that while the virus changes some blood factors, it doesn't seem to change how well patients do overall.
Methodology
Immunohistochemistry and in situ hybridization were used to investigate EBV expression in biopsies.
Limitations
The study does not establish a causal relationship between EBV status and clinical outcomes.
Participant Demographics
Patients with untreated Hodgkin’s disease, median follow-up time of 145 months.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website